Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry
Erica J. Brenner(University of North Carolina Health Care), Michael D. Kappelman(University of North Carolina at Chapel Hill), Jean‐Frédéric Colombel(Icahn School of Medicine at Mount Sinai), Gilaad G. Kaplan(University of Calgary), Ryan C. Ungaro(Icahn School of Medicine at Mount Sinai), Richard B. Gearry(New Leaders), James D. Lewis(University of Pennsylvania), Siew C. Ng(Chinese University of Hong Kong), Frank M. Ruemmele(Délégation Paris 5), Jean‐François Rahier(UCLouvain), Flávio Steinwurz(Hospital Israelita Albert Einstein), Michele Kissous-Hunt(Mount Sinai Medical Center), Xian Zhang(University of North Carolina at Chapel Hill), Fox E. Underwood(University of Calgary), Walter Reinisch(Medical University of Vienna)
Cited by 692
Related Papers
Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes
|Science|2011|6.6k
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
|Nature Medicine|2013|4.4k